-transparent.png){kind=logo}
The availability of target proteins in sufficient quantity is a limiting factor in crystallographic studies and therefore in rational drug design. Even after optimisation, expression of recombinant proteins may be low and the only way to produce enough protein is by large scale cell growth/purification. HIV-1 proteinase in Escherichia coli, which due to its toxicity is expressed as a soluble protein only at around 0.1% of total protein, is a paradigm for this. In this paper a detailed process for large scale expression and purification of HIV-1 proteinase which delivers material of suitable quantity (30 mg from 500 g of wet weight of cells) and quality for crystallographic studies is described.
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
June 2011,
Methods (San Diego, Calif.),
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
January 2000,
Methods in enzymology,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
October 2001,
Protein expression and purification,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
June 1993,
Journal of protein chemistry,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
January 2012,
Applied microbiology and biotechnology,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
January 2013,
PloS one,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
June 1994,
Veterinary immunology and immunopathology,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
December 1993,
Biotechnology and applied biochemistry,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
January 2019,
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
O M Singh, and
D S Baines, and
R M Hall, and
N M Gray, and
M P Weir
August 2007,
Protein expression and purification,
